| 107226-3 | Doxazosin (Urine, qualitative) | DRUG/TOX |
| 107227-1 | Carvedilol (Urine, qualitative) | DRUG/TOX |
| 107228-9 | amLODIPine (Urine, qualitative) | DRUG/TOX |
| 107229-7 | Anti-hypertensive drug panel - Urine | PANEL.DRUG/TOX |
| 10723-5 | Toxoplasma gondii IgA Ab (immunoassay) | MICRO |
| 107230-5 | levETIRAcetam (Urine, qualitative, confirmatory method) | DRUG/TOX |
| 107231-3 | Natriuretic peptide B adjusted for eGFR | CHEM |
| 107232-1 | Ankle - left Circumference | BDYCRC.MOLEC |
| 107233-9 | Weight of Adrenal gland | PATH |
| 107234-7 | Ankle - right Circumference | BDYCRC.MOLEC |
| 107235-4 | Weight of Lung - bilateral | PATH |
| 107236-2 | Sjogrens syndrome-A extractable nuclear 60kD IgG Ab (immunoassay) | SERO |
| 107237-0 | Fetal Maternal age | OBGYN |
| 107238-8 | CD169 monocytes/Monocytes (Blood) | CELLMARK |
| 107239-6 | 1p and 19q chromosome deletion (Tissue, fish) | MOLPATH.DELDUP |
| 10724-3 | Toxoplasma gondii IgE Ab (immunoassay) | MICRO |
| 107240-4 | Clonality analysis of Ig receptor genes in Specimen Document (sequencing) | PATH |
| 107241-2 | Measurable residual disease analysis in Specimen Qualitative (qualitative, sequencing) | PATH |
| 107242-0 | Tick borne encephalitis virus Ab | MICRO |
| 107243-8 | Rh antigens C little c E little e panel - Red Blood Cells | PANEL.BLDBK |
| 107244-6 | Busulfan --5H post busulfan infusion completion | DRUG/TOX |
| 107245-3 | Busulfan --3H post busulfan infusion completion | DRUG/TOX |
| 107246-1 | Busulfan --15M post busulfan infusion completion | DRUG/TOX |
| 107247-9 | Total number of doses | DRUG/TOX |
| 107248-7 | Test dose included in cumulative AUC Qualitative (qualitative) | DRUG/TOX |
| 107249-5 | Test dose Qualitative (qualitative) | DRUG/TOX |
| 10725-0 | Toxoplasma gondii DNA (Body Fluid, probe with amplification) | MICRO |
| 107250-3 | NUP98 11p15.4 gene rearrangement or Tissue (Blood, fish nominal) | MOLPATH.REARRANGE |
| 107251-1 | ASXL1 gene mutations found or Tissue (Blood, sequencing nominal) | MOLPATH.MUT |
| 107252-9 | CSF3R gene mutations found or Tissue (Blood, sequencing nominal) | MOLPATH.MUT |
| 107253-7 | CBL gene mutations found or Tissue (Blood, sequencing nominal) | MOLPATH.MUT |
| 107254-5 | CALR gene exon 9 mutations found or Tissue (Blood, sequencing nominal) | MOLPATH.MUT |
| 107255-2 | MPL gene mutations tested for or Tissue (Blood, sequencing nominal) | MOLPATH.MUT |
| 107256-0 | PDGFRA gene full mutation analysis or Tissue (Blood, qualitative, sequencing) | MOLPATH |
| 107257-8 | Naloxone/Creatinine (Urine) | DRUG/TOX |
| 107258-6 | RF Guidance for percutaneous thrombolysis of Cerebral artery | RAD |
| 107259-4 | RF Guidance for embolization of arteriovenous malformation of Unspecified body region | RAD |
| 10726-8 | Toxoplasma gondii (Tissue, qualitative, giemsa stain) | MICRO |
| 107262-8 | RF Guidance for percutaneous mechanical thrombectomy of Right pulmonary artery | RAD |
| 107263-6 | RF Guidance for percutaneous thrombolysis of Right pulmonary arteries | RAD |
| 107264-4 | RF Guidance for percutaneous mechanical thrombectomy of Pulmonary artery | RAD |
| 107265-1 | RF Guidance for percutaneous thrombolysis of Pulmonary artery | RAD |
| 107266-9 | RF Guidance for percutaneous thrombolysis of Mesenteric artery | RAD |
| 107267-7 | RF Guidance for percutaneous aspiration thrombectomy of Lower extremity artery - left | RAD |
| 107268-5 | RF Guidance for embolization of Carotid arteries - left | RAD |
| 107269-3 | RFA Guidance for embolization of Cerebral artery | RAD |
| 10727-6 | Toxoplasma gondii identified (Tissue) | MICRO |
| 107270-1 | RFA Guidance for insertion of stent of Carotid arteries -right | RAD |
| 107271-9 | XR and RF Wrist - right Views | RAD |
| 107272-7 | XR and RF Wrist - left Views | RAD |